Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 14 matching records
MISSION BIO TAPESTRI SINGLE CELL DNA SEQUENCING BIOLEGEND INC:1135351 [26-004813]Department of Health and Human Services$22.8K obligationsEnds Nov 12, 2026
TOTALSEQ-D HUMAN HEME ONCOLOGY COCKTAIL BIOLEGEND INC:1135351 [26-004804]Department of Health and Human Services$16.5K obligationsEnds Sep 30, 2026
BIOLEGEND INC. AMBIS 2094398Department of Health and Human Services$10.6K obligationsEnds Oct 17, 2021
BIOLOGICAL AND REAGENT MATERIAL - BIOLEGEND FLOW CYTOMETER ANTIBODIESDepartment of Health and Human Services$14.0K obligationsEnds Oct 21, 2025
[25-014521]NIH NHLBI LABORATORY OF IMMUNE REGULATORY GENOMICS AND EPIGENOMICS REQUIRES TOTAL SEQ ANTIBODY COCKTAILS (MIXTURES OF ANTIBODIES CONJUGATED TO DNA OLIGONUCLEOTIDES FOR…Department of Health and Human Services$10.5K obligationsEnds Nov 11, 2025
BIOLEGEND TOTALSEQ-C REAGENTSDepartment of Health and Human Services$49.0K obligationsEnds Oct 9, 2025
[25-012698] THE LAB REQUIRES ANTIBODIES IN ORDER TO FOR IMMUNE CELL DISTRIBUTION AND FUNCTION IN SLEEP STUDY.Department of Health and Human Services$23.0K obligationsEnds Nov 5, 2025
BIOLEGEND, ANTIBODIES, SEE QUOTE- 1XAJL033125-NIAIDDepartment of Health and Human Services$16.2K obligationsEnds Jun 30, 2025
[25-007798] LABS REQUIRE ANTIBODIES AND KITS FOR CELL ISOLATION IN ORDER TO FURTHER IDENTIFY CERTAIN CELLS THAT MAY AFFECT THE IMMUNE SYSTEM.Department of Health and Human Services$13.3K obligationsEnds Jul 1, 2025
ANTIBODIES FOR CLINICAL TRIAL PROTOCOL, WE WILL BE PERFORMING MULTI-PARAMETER FLOW-CYTOMETRIC ANALYSES FOR CIRCULATING IMMUNE SUBSETS ON OVER 230 CLINICAL SAMPLES, REQUIRING 30…Department of Health and Human Services$14.9K obligationsEnds May 21, 2025
BRILLIANT VIOLET ANTI-HUMAN ANTIBODIESDepartment of Health and Human Services$8.4K obligationsEnds Nov 29, 2022
[25-007670] NHLBI DIR CCMPB REQUIRES ANTIBODIES IN ORDER TO ASSESS ANTIGENS ON THE SURFACE WITHIN BLOOD SAMPLES BY FLOW CYTOMETRYDepartment of Health and Human Services$11.1K obligationsEnds May 20, 2025
BIOLEGEND (AMBIS #2251721) BIOLOGICAL PRODUCTS, REAGENTSDepartment of Health and Human Services$56.8K obligationsEnds Mar 31, 2025
25-001224 BIOLEGEND INC REAGENTS AND KITSDepartment of Health and Human Services$14.9K obligationsEnds May 28, 2025